Evidence map›Paper›PMID 34998247›Full record

ArticleDrug and alcohol dependence2022

Short-term binge drinking, marijuana, and recreational drug use trajectories in a prospective cohort of people living with HIV at the start of COVID-19 mitigation efforts in the United States.

Steven Meanley, Seul Ki Choi, Azure B Thompson, Jacquelyn L Meyers, Gypsyamber D'Souza, Adaora A Adimora, Matthew J Mimiaga, Mirjam-Colette Kempf, Deborah Konkle-Parker, Mardge H Cohen and 9 more

Open access · greenAbstract read
In one paragraph

Article in Drug and alcohol dependence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Psychological and Clinical Risk Factors for Substance Use in People With and Without HIV.Journal of the International Association of Providers of AIDS Care
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 1 country.

Steven MeanleyUniversity of Pennsylvania School of Nursing, Department of Family and Community Health, Philadelphia, PA, United States. Electronic address: smeanley@nursing.upenn.edu.
Seul Ki ChoiUniversity of Pennsylvania School of Nursing, Department of Family and Community Health, Philadelphia, PA, United States. Electronic address: skchoi@nursing.upenn.edu.
Azure B ThompsonSUNY Downstate Health Sciences University School of Medicine School of Public Health, Department of Community Health Sciences, Brooklyn, NY, United States. Electronic address: Azure.Thompson@downstate.edu.
Jacquelyn L MeyersSUNY Downstate Health Sciences University School of Medicine, Department of Psychiatry, Brooklyn, NY, United States. Electronic address: jacquelyn.meyers@downstate.edu.
Gypsyamber D'SouzaJohns Hopkins Bloomberg School of Public Health, Department of Epidemiology, Baltimore, MD, United States. Electronic address: gdsouza2@jhu.edu.
Adaora A AdimoraUniversity of North Carolina School of Medicine, Division of Infectious Diseases, Chapel Hill, NC, United States. Electronic address: adimora@med.unc.edu.
Matthew J MimiagaUniversity of California - Los Angeles Fielding School of Public Health, Department of Epidemiology, Los Angeles, CA, United States. Electronic address: mmimiaga@ph.ucla.edu.
Mirjam-Colette KempfUniversity of Alabama at Birmingham, School of Nursing, Medicine and Public Health Birmingham, AL, United States. Electronic address: mkempf@uab.edu.
Deborah Konkle-ParkerThe University of Mississippi Medical Center, Schools of Nursing, Medicine, and Population Health, Jackson, MS, United States. Electronic address: dkparker@umc.edu.
Mardge H CohenRush University Department of Medicine and Stroger Hospital of Cook County, Chicago, IL, United States. Electronic address: mardge.cohen@gmail.com.
Linda A TeplinNorthwestern University Feinberg School of Medicine, Department of Psychiatry and Behavioral Sciences, Chicago, IL, United States. Electronic address: L-Teplin@northwestern.edu.
Lynn MurchisonAlbert Einstein College of Medicine/Montefiore Medical Center, Division of General Internal Medicine, Bronx, NY, United States. Electronic address: lmurchis@montefiore.org.
Leah H RubinJohns Hopkins University School of Public Health, Department of Epidemiology, Baltimore, MD, United States; Johns Hopkins University School of Medicine, Departments of Neurology and Psychiatry and Behavioral Sciences, Baltimore, MD, United States. Electronic address: lrubin@jhu.edu.
Anna A RubtsovaEmory University Rollins School of Public Health, Department of Behavioral, Social, Health Education Sciences, Atlanta, GA, United States. Electronic address: grubtso@emory.edu.
Deborah Jones WeissUniversity of Miami Miller School of Medicine, Department of Psychiatry and Behavioral Sciences, Miami, FL, United States. Electronic address: d.jones3@med.miami.edu.
Brad AouizeratNew York University College of Dentistry, Department of Oral and Maxillofacial Surgery and Bluestone Center for Clinical Research, New York, NY, United States. Electronic address: bea4@nyu.edu.
Mackey R FriedmanUniversity of Pittsburgh Graduate School of Public Health, Department of Infectious Diseases and Microbiology, Pittsburgh, PA, United States. Electronic address: mrf9@pitt.edu.
Michael W PlankeyGeorgetown University Medical Center, Division of Infectious Diseases, Washington, DC, United States. Electronic address: mwp23@georgetown.edu.
Tracey E WilsonSUNY Downstate Health Sciences University School of Public Health, Department of Community Health Sciences, Brooklyn, NY, United States. Electronic address: tracey.wilson@downstate.edu.
SUNY Downstate Health Sciences University · USEmory University · USJohns Hopkins University · USMontefiore Medical Center · USNew York University · USNorthwestern University · USUniversity of Alabama at Birmingham · USUniversity of Mississippi Medical Center · USUniversity of North Carolina at Chapel Hill · USUniversity of Pennsylvania · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul A. Goepfert · 1988 to 2026
$84.1M
Engaging University of California Stakeholders for Biorespository ResearchUL1TR000004 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$78.0M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
QAQC Johns Hopkins Institute for Clinical and Translational ResearchUL1TR003098 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2019 to 2023
$57.7M
SF Bay Area MACS/WIHS Combined Cohort StudyU01HL146242 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Bradley E Aouizerat, Jennifer Cohen Price · 2019 to 2026
$36.3M
Sex differences in the role of multi-omicsin HIV-associated carotid artery atherosclerosisU01HL146193 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Stephen J Gange, Elizabeth Topper · 2019 to 2026
$35.8M
University of Miami Developmental Center for AIDS Research (D-CFAR)P30AI073961 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Savita Pahwa · 2007 to 2026
$33.8M
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center - Admin Supplement: Vision and dual sensory loss in HIV-infected older adultsU01HL146201 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI TODD T BROWN, Joseph B. Margolick · 2019 to 2026
$33.7M
Sex differences in the role of multi-omics in HIV-associated carotid artery atherosclerosisU01HL146204 · NHLBI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI David B. Hanna, Anjali Sharma · 2019 to 2026
$33.2M
University of Pittsburgh MWCCS Clinical Research SiteU01HL146208 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Bernard Jonas C Macatangay, CHARLES R RINALDO · 2019 to 2026
$32.2M
NCATS NIH HHS UL1 TR000004NCATS NIH HHS UL1 TR001881NCATS NIH HHS UL1 TR003098NHLBI NIH HHS U01 HL146192NHLBI NIH HHS U01 HL146193NHLBI NIH HHS U01 HL146194NHLBI NIH HHS U01 HL146201NHLBI NIH HHS U01 HL146202NHLBI NIH HHS U01 HL146203NHLBI NIH HHS U01 HL146204NHLBI NIH HHS U01 HL146205NHLBI NIH HHS U01 HL146208NHLBI NIH HHS U01 HL146240NHLBI NIH HHS U01 HL146241NHLBI NIH HHS U01 HL146242NHLBI NIH HHS U01 HL146245NHLBI NIH HHS U01 HL146333NIAID NIH HHS P30 AI027767NIAID NIH HHS P30 AI050409NIAID NIH HHS P30 AI050410NIAID NIH HHS P30 AI073961NIMHD NIH HHS R01 MD010680NIMH NIH HHS P30 MH116867NIMH NIH HHS R01 MH128955
6 · The paper itself

Abstract

backgroundAt the start of the COVID-19 pandemic, HIV experts suggested that an increase in mental health diagnoses and substance use among people living with HIV (PLHIV) may be an unintended consequence of COVID-19 mitigation efforts (e.g., limiting social contact). We evaluated short-term trajectories in binge drinking, marijuana, and recreational drug use in a prospective cohort of PLHIV.

methodsData (N = 2121 PLHIV) consist of survey responses on substance use behaviors from two pre-COVID-19 (October 2018-September 2019) and one COVID-19-era (April 2020-September 2020) timepoints within the MACS/WIHS Combined Cohort Study (MWCCS). We conducted group-based trajectory models, triangulated with generalized linear mixed models, to assess changes in binge drinking, daily marijuana use, and recreational drug use at the start of the pandemic. Controlling for age and race/ethnicity, we tested whether trajectories differed by sex and early-pandemic depressive symptoms, loneliness, and social support.

resultsGroup-based trajectory models yielded two trajectory groups for binge drinking (none vs. any), marijuana (none/infrequent vs. daily), and recreational drug use (none vs. any). Binge drinking and recreational drug use decreased at the beginning of the pandemic. Generalized linear mixed model supported these trends. Consistent with prior research, male sex and having depressive symptoms early pandemic were positively associated with each substance use outcomes. Social support was inversely associated with recreational drug use.

conclusionsContrary to hypotheses, problematic substance use behaviors decreased from pre-pandemic to the post-pandemic follow-up in our sample of PLHIV. Ongoing surveillance is needed to assess whether this pattern persists as the pandemic continues.

Indexed as

Binge DrinkingCannabisCOVID-19HIV InfectionsSubstance-Related DisordersCohort StudiesHumansMalePandemicsProspective StudiesRecreational Drug UseSARS-CoV-2United StatesCOVID-19HIVLongitudinalSubstance use

Identifiers

PMID34998247
PMCPMC8709730
OpenAlexW4200258479

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.